AIDS

1. BYONANEBYE DM
   Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents.
   AIDS. 2021 Jan 13. pii: 00002030-900000000-96508.
   

   >> Share

   
   
2. KANG R, Li J, Chen H, Tang Z, et al
   Using longitudinal genetic-network study to understand HIV treatment-as-prevention: a population-based observational study.
   AIDS. 2021 Jan 13. pii: 00002030-900000000-96507.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

3. KOUAMOU V, Mavetera J, Manasa J, Ndhlovu CE, et al
   Pre-treatment HIV Drug Resistance Among Adults Initiating or Re-initiating 1st Line Antiretroviral Therapy in Zimbabwe: Fast-tracking the Transition to Dolutegravir Based 1st Line Regimens?
   AIDS Res Hum Retroviruses. 2021 Jan 11. doi: 10.1089/AID.2020.0242.
   

   >> Share

   
   
4. BERARD AR, Miller C, Arainga M, Broedlow CA, et al
   SIV susceptibility, immunology and microbiome in the female genital tract of adolescent versus adult pigtail macaques.
   AIDS Res Hum Retroviruses. 2021 Jan 15. doi: 10.1089/AID.2020.0271.
   

   >> Share

   
   
5. LI J, Gao L, Ye Z
   Study of Brain Structure in HIV Vertically Infected Adolescents.
   AIDS Res Hum Retroviruses. 2021 Jan 11. doi: 10.1089/AID.2020.0030.
   

   >> Share

   
   
6. AUGIER C, Beyne E, Villabona-Arenas CJ, Mpoudi Ngole E, et al
   Identification of a Novel Simian Immunodeficiency Virus-Infected African Green Monkey (Chlorocebus tantalus) Confirms that Tantalus Monkeys in Cameroon Are Infected with a Mosaic SIVagm Lineage.
   AIDS Res Hum Retroviruses. 2020;36:167-170.
   

   >> Share

   
   

   
   BMC Pediatr

7. ADETORO D, Khamofu H, Badru T, Markson J, et al
   Correlates of uptake of HIV testing among children and young adolescents in Akwa-Ibom state, Nigeria: a secondary data analysis of the Akwa-Ibom aids indicator survey, 2017.
   BMC Pediatr. 2021;21:33.
   

   >> Share

   
   

   
   Clin Infect Dis

8. GUNASEKERA KS, Walters E, van der Zalm MM, Palmer M, et al
   Development of a treatment-decision algorithm for HIV-uninfected children evaluated for pulmonary tuberculosis.
   Clin Infect Dis. 2021 Jan 15. pii: 6101512. doi: 10.1093.
   

   >> Share

   
   

   
   HIV Med

9. NOCELLA C, Mezzaroma I, Cammisotto V, Castellani V, et al
   Lipopolysaccharide induces platelet activation in HIV patients: the role of different viral load patterns.
   HIV Med. 2021 Jan 10. doi: 10.1111/hiv.13059.
   

   >> Share

   
   

   
   J Acquir Immune Defic Syndr

10. GATHE JC, Hardwicke RL, Garcia F, Weinheimer S, et al
    Efficacy, pharmacokinetics and safety over 48 weeks with ibalizumab-based therapy in treatment-experienced adults infected with HIV-1: A Phase 2a study.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    

    >> Share

    
    
11. CRANE HM, Nance RM, Whitney BM, Heckbert SR, et al
    Brief Report: Differences in Types of Myocardial Infarctions Among People Aging With HIV.
    J Acquir Immune Defic Syndr. 2021;86:208-212.
    

    >> Share

    
    
12. MUCCINI C, Crowell TA, Pinyakorn S, Kroon E, et al
    Brief Report: Syphilis Incidence and Effect on Viral Load, CD4, and CD4/CD8 Ratio in a Thai Cohort of Predominantly Men Who Have Sex With Men Living With HIV.
    J Acquir Immune Defic Syndr. 2021;86:219-223.
    

    >> Share

    
    
13. PATEL VV, Felsen UR, Fisher M, Fazzari MJ, et al
    Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19.
    J Acquir Immune Defic Syndr. 2021;86:224-230.
    

    >> Share

    
    
14. RAO A, Rucinski K, Jarrett B, Ackerman B, et al
    Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries.
    J Acquir Immune Defic Syndr. 2021 Jan 13. pii: 00126334-900000000-95967.
    

    >> Share

    
    
15. DIRAJLAL-FARGO S, Williams PL, Broadwell C, McFARLAND EJ, et al
    Youth living with perinatally-acquired HIV have lower physical activity levels as they age compared to HIV-exposed uninfected youth.
    J Acquir Immune Defic Syndr. 2021 Jan 13. pii: 00126334-900000000-95968.
    

    >> Share

    
    

    
    J Med Virol

16. HUANG XH, Yu G, Zheng C, Zhou PP, et al
    Genomic characterization of a new CRF01_AE/CRF07_BC case from a MSM patient in Guangdong, China.
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26799.
    

    >> Share

    
    
17. RAMASWAMY M, Bruden D, Nolen LD, Mosites E, et al
    Hepatitis A vaccine immunogenicity 25 years after vaccination in Alaska.
    J Med Virol. 2020 Jul 22. doi: 10.1002/jmv.26327.
    

    >> Share

    
    
18. PATRA R, Chandra Das N, Mukherjee S
    Targeting human TLRs to combat COVID-19: A solution?
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26387.
    

    >> Share

    
    

    
    J Virol

19. SANGARE K, Tuero I, Rahman MA, Hoang T, et al
    The immunological impact of adenovirus early genes on vaccine-induced responses in mice and nonhuman primates.
    J Virol. 2021 Jan 13. pii: JVI.02253-20. doi: 10.1128/JVI.02253.
    

    >> Share

    
    
20. MATSUOKA S, Kuwata T, Ishii H, Sekizuka T, et al
    A Potent anti-Simian Immunodeficiency Virus Neutralizing Antibody Induction Associated with a Germline Immunoglobulin Gene Polymorphism in Rhesus Macaques.
    J Virol. 2021 Jan 13. pii: JVI.02455-20. doi: 10.1128/JVI.02455.
    

    >> Share

    
    
21. SARABIA I, Huang SH, Ward AR, Jones RB, et al
    The Intact Non-Inducible Latent HIV-1 Reservoir is Established In an In Vitro Primary TCM Cell Model of Latency.
    J Virol. 2021 Jan 13. pii: JVI.01297-20. doi: 10.1128/JVI.01297.
    

    >> Share

    
    
22. MAYBERRY CL, Wilczek MP, Fong TM, Nichols SL, et al
    GRK2 mediates beta-arrestin interactions with 5-HT2 receptors for JC polyomavirus endocytosis.
    J Virol. 2021 Jan 13. pii: JVI.02139-20. doi: 10.1128/JVI.02139.
    

    >> Share

    
    

    
    PLoS Genet

23. FEDER AF, Pennings PS, Petrov DA
    The clarifying role of time series data in the population genetics of HIV.
    PLoS Genet. 2021;17:e1009050.
    

    >> Share

    
    

    
    PLoS Med

24. STELZLE D, Godfrey-Faussett P, Jia C, Amiesimaka O, et al
    Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis.
    PLoS Med. 2021;18:e1003482.
    

    >> Share

    
    
25. MEFFERT SM, Neylan TC, McCulloch CE, Blum K, et al
    Interpersonal psychotherapy delivered by nonspecialists for depression and posttraumatic stress disorder among Kenyan HIV-positive women affected by gender-based violence: Randomized controlled trial.
    PLoS Med. 2021;18:e1003468.
    

    >> Share

    
    

    
    PLoS One

26. LINSTROM MA, Preiser W, Nkosi NN, Vreede HW, et al
    HIV false positive screening serology due to sample contamination reduced by a dedicated sample and platform in a high prevalence environment.
    PLoS One. 2021;16:e0245189.
    

    >> Share

    
    
27. HEFFERNAN A, Ma Y, Nayagam S, Chan P, et al
    Economic and epidemiological evaluation of interventions to reduce the burden of hepatitis C in Yunnan province, China.
    PLoS One. 2021;16:e0245288.
    

    >> Share

    
    
28. MAPANGISANA T, Machekano R, Kouamou V, Maposhere C, et al
    Viral load care of HIV-1 infected children and adolescents: A longitudinal study in rural Zimbabwe.
    PLoS One. 2021;16:e0245085.
    

    >> Share

    
    
29. DADRAS O, Nakayama T, Kihara M, Ono-Kihara M, et al
    The prevalence and associated factors of adverse pregnancy outcomes among Afghan women in Iran; Findings from community-based survey.
    PLoS One. 2021;16:e0245007.
    

    >> Share

    
    
30. NGUGI P, Babic A, Kariuki J, Santas X, et al
    Development of standard indicators to assess use of electronic health record systems implemented in low-and medium-income countries.
    PLoS One. 2021;16:e0244917.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

31. LIU H, Xu J, Yang Y, Wang X, et al
    Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    
32. HAYN M, Blotz A, Rodriguez A, Vidal S, et al
    Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    
33. MONTEFIORI DC, Filsinger Interrante MV, Bell BN, Rubio AA, et al
    The high-affinity immunoglobulin receptor FcgammaRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat.
    Proc Natl Acad Sci U S A. 2021;118.
    

    >> Share

    
    

    
    Science

34. HIE B, Zhong ED, Berger B, Bryson B, et al
    Learning the language of viral evolution and escape.
    Science. 2021;371:284-288.
    

    >> Share

    
    

    
    Vaccine

35. CALDERA F, Mercer M, Samson SI, Pitt JM, et al
    Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity.
    Vaccine. 2021 Jan 7. pii: S0264-410X(20)31490.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share